Last edition
News about "small molecule therapies "
Biogen Closes Acquisition of RayThera
Biogen completes the acquisition of RayThera Inc., adding a phase 1 lead program to strengthen its pipeline and advance innovative therapeutic development.
Small Molecule Therapies | 07/08/2026 | By News Bureau
Can-Fite BioPharma Secures Australian Patent for Namodenoson in Advanced Metastatic Cancer
Can-Fite BioPharma has secured an Australian patent covering the use of Namodenoson for advanced metastatic cancer, strengthening intellectual property protection as the drug advances through late-stage clinical development for liver and pancreatic cancers.
Small Molecule Therapies | 15/07/2026 | By News Bureau
Brenig Therapeutics Initiates First-in-Human Study of BT-409, Advances BT-267 Parkinson's Programme
Brenig Therapeutics has launched a first-in-human Phase I study of BT-409, a brain-selective NLRP3 inhibitor, while advancing BT-267 toward Phase 1b and Phase II studies in Parkinson’s disease.
Small-molecule Therapies | 20/01/2026 | By News Bureau | 446
Skyhawk Therapeutics Inaugurates its State-of-the-Art Labs in Switzerland
Skyhawk Therapeutics, Inc. has expanded its facilities with its new state-of-the-art labs in Superlab Suisse, in Basel Switzerland.
Small Molecule Therapies | 26/06/2024 | By Aishwarya | 1153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy